Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study

Roy O. Mathew; Mandeep S. Sidhu; Charanjit S. Rihal; Ryan Lennon; Mohammed El-Hajjar; Neil Yager; Radmila Lyubarova; Khaled Abdul-Nour; Steven Weitz; D. Fearghas O’Cochlain; Vishakantha Murthy; Justin Levisay; Kevin Marzo; John Graham; Vlad Dzavik; Derek So; Shaun Goodman; Yves D. Rosenberg; Naveen Pereira; Michael E. Farkouh

doi:10.1007/s10557-022-07392-2

Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y₁₂ Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study

Roy O. Mathew, Mandeep S. Sidhu, Charanjit S. Rihal, Ryan Lennon, Mohammed El-Hajjar, Neil Yager, Radmila Lyubarova, Khaled Abdul-Nour, Steven Weitz, D. Fearghas O’Cochlain, Vishakantha Murthy, Justin Levisay, Kevin Marzo, John Graham, Vlad Dzavik, Derek So, Shaun Goodman, Yves D. Rosenberg, Naveen Pereira, Michael E. Farkouh

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	447-457
Number of pages	11
Journal	Cardiovascular Drugs and Therapy
Volume	38
Issue number	3
DOIs	https://doi.org/10.1007/s10557-022-07392-2
State	Published - Jun 2024
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Keywords

Antiplatelet therapy
CYP2C19
Chronic kidney disease
Coronary artery disease
Percutaneous coronary intervention
Pharmacogenomics

Access to Document

10.1007/s10557-022-07392-2

OpenUrl availability

Full text

Cite this

Mathew, R. O., Sidhu, M. S., Rihal, C. S., Lennon, R., El-Hajjar, M., Yager, N., Lyubarova, R., Abdul-Nour, K., Weitz, S., O’Cochlain, D. F., Murthy, V., Levisay, J., Marzo, K., Graham, J., Dzavik, V., So, D., Goodman, S., Rosenberg, Y. D., Pereira, N., & Farkouh, M. E. (2024). Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y₁₂ Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovascular Drugs and Therapy, 38(3), 447-457. https://doi.org/10.1007/s10557-022-07392-2

Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y₁₂ Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. / Mathew, Roy O.; Sidhu, Mandeep S.; Rihal, Charanjit S. et al.
In: Cardiovascular Drugs and Therapy, Vol. 38, No. 3, 06.2024, p. 447-457.

Research output: Contribution to journal › Article › peer-review

Mathew, RO, Sidhu, MS, Rihal, CS, Lennon, R, El-Hajjar, M, Yager, N, Lyubarova, R, Abdul-Nour, K, Weitz, S, O’Cochlain, DF, Murthy, V, Levisay, J, Marzo, K, Graham, J, Dzavik, V, So, D, Goodman, S, Rosenberg, YD, Pereira, N & Farkouh, ME 2024, 'Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y₁₂ Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study', Cardiovascular Drugs and Therapy, vol. 38, no. 3, pp. 447-457. https://doi.org/10.1007/s10557-022-07392-2

@article{5f29606b640b4810971780f9b6b7b25b,

title = "Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study",

keywords = "Antiplatelet therapy, CYP2C19, Chronic kidney disease, Coronary artery disease, Percutaneous coronary intervention, Pharmacogenomics",

author = "Mathew, {Roy O.} and Sidhu, {Mandeep S.} and Rihal, {Charanjit S.} and Ryan Lennon and Mohammed El-Hajjar and Neil Yager and Radmila Lyubarova and Khaled Abdul-Nour and Steven Weitz and O{\textquoteright}Cochlain, {D. Fearghas} and Vishakantha Murthy and Justin Levisay and Kevin Marzo and John Graham and Vlad Dzavik and Derek So and Shaun Goodman and Rosenberg, {Yves D.} and Naveen Pereira and Farkouh, {Michael E.}",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.",

year = "2024",

month = jun,

doi = "10.1007/s10557-022-07392-2",

language = "English",

volume = "38",

pages = "447--457",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

number = "3",

}

TY - JOUR

T1 - Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease

T2 - a Post Hoc Analysis of the TAILOR-PCI Study

AU - Mathew, Roy O.

AU - Sidhu, Mandeep S.

AU - Rihal, Charanjit S.

AU - Lennon, Ryan

AU - El-Hajjar, Mohammed

AU - Yager, Neil

AU - Lyubarova, Radmila

AU - Abdul-Nour, Khaled

AU - Weitz, Steven

AU - O’Cochlain, D. Fearghas

AU - Murthy, Vishakantha

AU - Levisay, Justin

AU - Marzo, Kevin

AU - Graham, John

AU - Dzavik, Vlad

AU - So, Derek

AU - Goodman, Shaun

AU - Rosenberg, Yves D.

AU - Pereira, Naveen

AU - Farkouh, Michael E.

N1 - Publisher Copyright: © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.

PY - 2024/6

Y1 - 2024/6

KW - Antiplatelet therapy

KW - CYP2C19

KW - Chronic kidney disease

KW - Coronary artery disease

KW - Percutaneous coronary intervention

KW - Pharmacogenomics

UR - http://www.scopus.com/inward/record.url?scp=85142924959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142924959&partnerID=8YFLogxK

U2 - 10.1007/s10557-022-07392-2

DO - 10.1007/s10557-022-07392-2

M3 - Article

C2 - 36445624

AN - SCOPUS:85142924959

SN - 0920-3206

VL - 38

SP - 447

EP - 457

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 3

ER -